|
For the financial year ended 30th June 2014, the DCG Asia Value Fund’s Net Asset Value registered a gain of 9.8% with the NAV at S$165.86 per share. In comparison, the benchmark MSCI Asia ex Japan Index rose 14.4% over the same period. |
In the last 12 months these are the stocks that have contributed most to the portfolio’s performance.
Pax Global (“Pax”) is one of the world’s largest developer and seller of electronic fund transfer point-of-sales terminals and related services, with a leading market share in China. Pax’s stock price had a strong showing in the year, rising from about HK$1.7 per share in July 2013 to an all-time high of HK$5.15 in early June 2014.
The company continues to generate good revenue and earnings growth both in China and abroad, backed by solid cashflows and no debt. In June 14, the company announced that it had passed the verification process to be recognized as one of Shenzhen’s Key Software Enterprises. After the strong run-up, we sold our holdings in Pax as it had come close to our estimate of its intrinsic value.
Pax Global is one of the world’s largest developer and seller of electronic fund transfer point-of-sales terminals and related services. Photo: Company
Tiga Pila looking at spinning off its plantation business, Bumiraya Investindo, via an IPO in the second half of 2014. Photo: Internet Net sales grew 34% y-o-y to Rp1,153 billion while net profit attributable to shareholders jumped 49% y-o-y to Rp98 billion. Its food manufacturing business posted an impressive 58% y-o-y growth, driven primarily by dried noodle and vermicelli sales (up 92% y-o-y), and stronger sales of its Growie wafers and Taro extruded snacks (up 71% y-o-y). Tiga Pilar’s rice business, one of the key growth drivers for the group in the next three to five years, grew 21% y-o-y in sales to IDR654 billion, contributing over 56% of group revenue. In April 2014, the company commissioned its second rice milling facility, doubling its capacity to 480,000 tons per annum.Tiga Pilar is also looking at spinning off its plantation business, Bumiraya Investindo (“BRI”), via an IPO in the second half of 2014. BRI, which is 35% owned by Bungee, a leading US agriculture and food company, owns seven palm oil plantations with a total concession area of 93,000 hectares, of which only 16,740 hectares are planted.
Bonia Group's flagship fashion label is BONIA but it also holds the license to distribute international labels such as Santa Barbara Polo & Racquet Club, Austin Reed, Valentino Rudy, Jeep, The Savile Row Company, Braun Buffel, Pierre Cardin, Bruno Magli, Enrico Coveri, Renoma Café Gallery and Renoma. Photo: CompanyBonia, a seller of ladies handbags and other leather goods, has a network of over 700 sales outlets and 70 boutiques in Singapore, Malaysia, Vietnam and Phillippines. Its portfolio of brands include Bonia, Braun Buffel, Sembonia, Carlo Rino, Rudy Valentino, and Bruno Magli. Management has been buying back shares at below MYR2, and have attempted to privatize the company at MYR2.04 a share when the family’s stake crossed 50% in October 2012. Bonia is considered a mid-tier brand in Southeast Asia, where its growth has largely been driven by its operations in Vietnam and Indonesia.
We started acquiring the company’s shares at about MYR1.80 a share in May 2013, which was lower than the attempted privatization offer price. As at end June 2014, the stock price has risen to MYR5.44, trading at a PE ratio of 19.5x, with a net cash balance of MYR21 million on its balance sheet. We have top sliced our positions due to the reduced margin of safety at these elevated prices.
Daniel Glinert, executive chairman of Sarine Technologies. NextInsight file photo.Sarine recently launched two new imaging systems to target the polished diamond online and retail trade. The Sarine Light system provides an objective measure of a polished diamond’s appearance through its light performance. The Sarine Loupe system creates a high-quality, significantly enlarged multi-angle image of a polished diamond so that the viewer or potential buyer can inspect it through a conventional loupe without the diamond physically present. The successful launch of these two systems over the next three to five years could boost Sarine’s sales and earnings significantly. Other significant recent updates include the November announcement of a five-year collaboration with New York Diamond Dealers’ Club (“NYDDC”), the largest diamond trade organization in the United States (the world’s largest market for diamond jewellery sales) and one of the leading diamond exchanges in the world. In the strategic agreement, NYDDC will exclusively promote and market Sarine’s products to the US diamond industry in return for Sarine providing the latest technology for the use of NYDDC’s members. Sarine also announced a tie-up with the Rapaport Group’s RapNet, a web-based diamond trading network, to enhance online trade by providing diamond imagery produced by Sarine Loupe (on a pay-per-stone basis) alongside data on the diamond from the Gemological Institute of America.
MES entails all activities of the entire value chain of a product from sourcing, research and analysis, marketing, sales, distribution and logistics to after sales services. DKSH offers one-stop-shop solutions to clients who are looking for quick market access, local knowledge and a trustworthy business partner in the emerging Asia markets.
DKSH Malaysia employs about 3,600 people in a knowledge-based business model and acts as route-to-market specialists to provide market information, leading product and application expertise, marketing, sales and logistics expertise, and state-of-the-art IT. Photo: CompanyWith more than 90 years in the Malaysia market, DKSH (M) has established strong relationships with over 130 main clients, including the MNCs and local companies like Old Town, Vico, Maxis, supplying consumer products to over 25,000 retail outlets in Malaysia. In the healthcare logistics business, DKSH (M) distributes products for more than 69 international and local healthcare companies, reaching over 10,000 customers across various doctors’ clinics, retail pharmacies, private hospitals, government hospitals and institutions, and selected wholesalers. The information and materials contained in or accessed through this website are provided on an "as is" and "as available" basis and are of a general nature which have not been verified, considered or assessed by DCG Captital Pte. Ltd. ("DCG") in relation to the making of any specific investment, business, financial or commercial decision. Such information and materials are provided for general information only and you should seek professional advice at all times and obtain independent verification of the information and materials contained herein before making any decision based on any such information or materials.
DCG does not warrant the truth, accuracy, adequacy, completeness or reasonableness of the information and materials contained in or accessed through this website and expressly disclaims liability for any errors in, or omissions from, such information and materials. No warranty of any kind, implied, express or statutory (including but not limited to, warranties of title, merchantability, satisfactory quality, non-infringement of third-party intellectual property rights, fitness for a particular purpose and freedom from computer virus and other malicious code), is given in conjunction with such information and materials, or this website in general.
The views expressed are opinions of DCG and are subject to change based on market and other conditions. These views are not intended to be a forecast of future events, a guarantee of future results or investment advice. Nothing in this website constitutes accounting, legal, regulatory, tax or other advice.
Under no circumstances shall DCG be liable regardless of the form of action for any failure of performance, system, server or connection failure, error, omission, interruption, breach of security, computer virus, malicious code, corruption, delay in operation or transmission, transmission error or unavailability of access in connection with your accessing this website and/or using the online services even if DCG had been advised as to the possibility.
In no event shall DCG be liable to you or any other party for any damages, losses, expenses or costs whatsoever (including without limitation, any direct, indirect, special, incidental or consequential damages, loss of profits or loss opportunity) arising in connection with your use of this website, or reliance on any information, materials or online services provided at this website, regardless of the form of action and even if DCG had been advised as to the possibility of such damages.
DCG Capital Pte Ltd is a Registered Fund Management Company as defined in the Securities and Futures Act of Singapore ("SFA"). Accordingly, each client of DCG Capital Pte Ltd must be a qualified investor or accredited investor as defined under the Securities and Futures Act of Singapore (Cap. 289).
